Epstein barr virus induced lymphoma in a child with IPEX syndrome

Pediatric Blood and Cancer

Volumn 50, Issue 5, 2008, Pages 1056-1057

  Lucas, Kenneth G ^a   Ungar, David ^a   Comito, Melanie ^a   Groh, Brandt ^a  

^a PENN STATE CHILDREN S HOSPITAL   (United States)

Author keywords

Epstein Barr virus; Immunodeficiency; IPEX syndrome; Lymphoma; Rapamycin

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; VINCRISTINE;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNITY; CASE REPORT; CAUSE OF DEATH; CHILD; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; IPEX SYNDROME; LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

CHILD; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC DISEASES, X-LINKED; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSIVE AGENTS; INFANT; LYMPHOMA; MALE; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROTEIN-LOSING ENTEROPATHIES; SIROLIMUS; SYNDROME;

EID: 41849130326     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21341     Document Type: Article

References (12)

1. Lucas KG, Ungar D, Comito M, et al. Submyeloablative cord blood transplantation corrects clinical defects seen in IPEX syndrome. Bone Marrow Transplant 2007;39:55-56.
2. Rao A, Kamani N, Filipovich A, et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 2007;109:383-385.
3. Bindl L, Torgerson T, Perroni L, et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J Pediatr 2005;147:256-259.
4. Tai X, Cowan M, Feigenbaum L, et al. CD28 costimulation of developing thymocytes induces FOXP3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005;6:152-162.
5. Sakaguchi S. The origin of FOXP3-expressing CD4+ regulatory T cells: Thymus or periphery. J Clin Invest 2003;112:1310-1312.
6. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrin-opathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FO XP3. Nat Genet 2001; 27:20-21.
7. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39:537-545.
8. Powell BR, Buist NR, Stenzel P, An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982;100:731-737.
9. Peake JEMR, Byrne G, Shepherd R. X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhea. Arch Dis Child 1996;74:195-199.
10. Baud O, Goulet O, Canioni D, et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001;344:1758-1762.
11. Mazzolari E, Forino C, Fontana M, et al. A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant 2005;35:1033-1034.
12. Decker T, Hipp S, Ringshausen I, et al. Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood 2003;101: 278-285.